Masimo (MASI) FCF Margin Growth (1y) (2011 - 2026)
Masimo (MASI) FCF Margin Growth (1y) (2011 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | -80.00 |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 473.00 |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | -192.00 |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | -431.00 |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | -1,716.00 |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 2,833.00 |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 2,811.00 |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | -125.00 |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | Masimo | 9.39 Bn | 9.27 Bn | 250.80 Mn | 99.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 4, 2026 | 99.00 |
| Jan 3, 2026 | 696.00 |
| Sep 27, 2025 | 1,100.00 |
| Jun 28, 2025 | -916.00 |
| Mar 29, 2025 | -103.00 |
| Dec 28, 2024 | 6,303.00 |
| Sep 28, 2024 | 625.00 |
| Jun 29, 2024 | 2,427.00 |
| Mar 30, 2024 | 1,098.00 |
| Dec 30, 2023 | -4,764.00 |
| Sep 30, 2023 | -408.00 |
| Jul 1, 2023 | 530.00 |
| Apr 1, 2023 | -803.00 |
| Dec 31, 2022 | -5,773.00 |
| Apr 2, 2022 | -921.00 |
| Apr 3, 2021 | 1,485.00 |
| Sep 26, 2020 | -4,961.00 |
| Jun 27, 2020 | 2,550.00 |
| Mar 28, 2020 | -1,334.00 |
| Dec 28, 2019 | 214.00 |